Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate

Following completion of the full set of clinical studies, Dr Reddy's said it will now prepare to file in the US, European Union and other regions for approval of 'DRL_RI'.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/6iX1QKP
via IFTTT